A Monash University study revealed that less than 50% of fibromyalgia patients utilise evidence-based medication, largely due to the high cost. Researchers found that patients use various non-evidence-based therapeutics, often resulting in polypharmacy. This highlights the financial barriers hindering access to essential medication, calling for improved affordability through subsidisation. (50 words)
Read the full story here
Written by: Helen Tobler
Published on April 29, 2024 at 04:17PM
Source: Medical Republic (opens in new tab)